Indication

Acromegaly

Acromegaly is a rare, chronic endocrine disorder characterized by the autonomous hypersecretion of growth hormone (GH) following epiphyseal plate closure in adulthood, driven in most cases by a benign anterior pituitary adenoma. Read more about Acromegaly

48 drugs 41 manufacturers

Advertisement

Drugs that treat it

Common Acromegaly therapies.

Showing 37–45 of 48 drugs

Filter & compare in the drug finder →Opens the drug finder with Acromegaly preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Acromegaly.

Acromegaly is a rare, chronic endocrine disorder characterized by the autonomous hypersecretion of growth hormone (GH) following epiphyseal plate closure in adulthood, driven in most cases by a benign anterior pituitary adenoma.

Excess circulating GH stimulates the liver and peripheral tissues to overproduce insulin-like growth factor 1 (IGF-1), resulting in progressive somatic and soft-tissue overgrowth.

Patients classically develop coarse facial features, prognathism, macroglossia, and enlargement of the hands and feet.

If unaddressed, sustained hormone elevation contributes to multi-organ system complications, prominently including hypertension, cardiomyopathy, obstructive sleep apnea, type 2 diabetes mellitus, and osteoarthritis.

Personalize your experience

Follow Acromegaly and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it